Canada· CA-DIN-02248676
IRESSA
A gefitinib product containing gefitinib, registered in Canada by ASTRAZENECA CANADA INC. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Gefitinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EB01 (gefitinib), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Gefitinib · ATC L01EB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gefitinib costs, country by country.
Normalised to the WHO defined daily dose (0.25 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gefitinib · price per daily dose (0.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$95.15
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GEFITINIB
- Manufacturer
- ASTRAZENECA CANADA INC
- Country
- Canada (CA)
- ATC code
- L01EB01
- ATC class
- Gefitinib
- Defined daily dose
- 0.25 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
414 interactions on record for gefitinib.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gefitinib · interactions on record
414 records
- 11 severe
- 193 moderate
- 5 minor
- 205 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gefitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGefitinib 250mg tabletsSandoz Ltd
- NorwayGefitinib mylanMylan
- SpainGEFITINIB ACCORD 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FranceGEFITINIB ACCORD 250 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- NetherlandsGefitinib Eugia 250 mg filmomhulde tablettenEugia Pharma (Malta) Limited
- FinlandGefitinib AccordAccord Healthcare B.V.
- United StatesGefitinibTeva Pharmaceuticals, Inc.
- PolandGefitinib AccordAccord Healthcare Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Gefitinib Accord
- Belgium · Gefitinib Accord, Gefitinib Sandoz
- Bulgaria · Фромпо
- Cyprus · Refetib
- Czechia · Gefitinib Accord
- Germany · Gefitinib Accord, Gefitinib Genthon
- Denmark · Gefitinib Accord, Gefitinib Stada
- Estonia · Gefitinib Auxilia, Gefitinib Norameda
- Spain · Gefitinib Efg Genthon, Gefitinib Eugia
- Finland · Gefitinib Accord, Gefitinib Stada
- France · Gefitinib Arrow, Gefitinib Biogaran
- United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
- Greece · Gefitinib Faran, Gefitinib Genepharm
- Croatia · Gefitinib Pliva, Gefitinib Sandoz
- Hungary · Gefitinib Genepharm, Gefitinib Onkogen
- Iceland · Gefitinib Stada, Gefitinib Wh
- Italy · Gefitinib Medac
- Liechtenstein · Iressa
- Lithuania · Gefitinib Norameda
- Latvia · Gefitinib Norameda
- Malta · Gefitinib Eugia, Gefitinib Genthon
- Netherlands · Gefitinib Eugia, Gefitinib Genthon
- Norway · Gefitinib Stada, Iressa
- Poland · Gefitinib Accord, Gefitinib Genthon
- Portugal · Gefitinib Accord, Gefitinib Eugia
- Romania · Gefitinib Accord, Gefitinib Polisano
- Sweden · Gefitinib Accord, Gefitinib Stada
- Slovenia · Phrompo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4898df4-3f21-4f45-b527-5f29b9d2df38 GET /v1/drugs/b4898df4-3f21-4f45-b527-5f29b9d2df38?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02248676",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01EB01",
"schedule": [
"Prescription"
],
"drug_code": "73040",
"strengths": [
"250 MG"
],
"ahfs_class": null,
"substances": [
"GEFITINIB"
],
"product_categorization": null
}See everything about gefitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.